(Q34191019)

31 July 2017

title

Growth hormone treatment improves body composition in adults with Prader-Willi syndrome (English)

1 reference

31 July 2017

Growth hormone treatment improves body composition in adults with Prader–Willi syndrome (English)

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

25 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

25 December 2023

author name string

Charlotte Höybye

1

1 reference

31 July 2017

Agneta Hilding

2

1 reference

31 July 2017

Hans Jacobsson

3

1 reference

31 July 2017

Marja Thorén

4

1 reference

31 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12699450

25 December 2023

publication date

1 May 2003

1 reference

full work available at URL

31 July 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2265.2003.01769.x

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2265.2003.01769.x

25 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

25 December 2023

published in

Clinical Endocrinology

1 reference

31 July 2017

volume

58

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

653-661

1 reference

Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01769.X

Is there growth hormone deficiency in prader-willi Syndrome? Six arguments to support the presence of hypothalamic growth hormone deficiency in Prader-Willi syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01769.X

Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01769.X

Beneficial effects of growth hormone treatment in GH-deficient adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01769.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01769.X

The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01769.X

Cardiovascular risk factors improve during 3 years of growth hormone therapy in Prader-Willi syndrome

21 January 2018

2

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition

25 December 2023

5

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

Prevalence of insulin resistance in metabolic disorders: the Bruneck Study.

25 December 2023

6

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study

25 December 2023

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee.

25 December 2023

9

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

25 December 2023

Prader-Willi syndrome

10

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

A rapid, PCR based test for differential molecular diagnosis of Prader-Willi and Angelman syndromes

25 December 2023

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

Validity of methods of body composition assessment in young and older men and women

25 December 2023

12

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

Consensus Guidelines for the Diagnosis and Treatment of Adults with Growth Hormone Deficiency: Summary Statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency

25 December 2023

16

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

Metabolic profile and body composition in adults with Prader-Willi syndrome and severe obesity

25 December 2023

20

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence

25 December 2023

21

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults

25 December 2023

22

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

Deletions of chromosome 15 as a cause of the Prader-Willi syndrome

25 December 2023

24

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

Diagnosis of the Prader-Willi syndrome by proving the absence of the unmethylated PW71 DNA fragment

25 December 2023

25

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

Leptin concentrations in Prader-Willi syndrome before and after growth hormone replacement

25 December 2023

27

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid

25 December 2023

28

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects.

25 December 2023

31

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

25 December 2023

32

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

Glucose homeostasis in Prader-Willi syndrome and potential implications of growth hormone therapy.

25 December 2023

35

1 reference

https://api.crossref.org/works/10.1046/J.1365-2265.2003.01769.X

25 December 2023

Identifiers

1 reference

31 July 2017

1 reference